ABIO Shares Outstanding History
Below is a table of the ABIO shares outstanding history going back to 9/4/2015:

Date ABIO Shares Outstanding
9/4/2015501746
11/10/2015502845
3/15/2016503147
5/9/2016503686
8/5/2016503686
11/10/2016504576
3/17/2017507274
5/11/2017513460
7/31/2017652819
11/7/2017652832
3/19/2018773018
5/4/2018773546
8/7/2018773546
11/12/2018773559
2/22/20191.02M
4/4/20191.02M
5/6/20191.10M
7/31/20191.46M
11/1/20191.59M
2/13/20201.59M
5/5/20201.59M
3/16/202114.41M
5/10/202114.41M
8/3/202114.41M
11/1/202114.41M
3/11/202214.41M
4/29/202214.41M
8/1/202214.41M

Also see: ABIO Market Cap History
ABIO YTD Return
ABIO Historical Shares Outstanding:
+62.54% CAGR
ABIO Historical Shares Outstanding: +62.54% CAGR

Mouse over chart for data details
9/4/2015 ...8/1/2022
ARCA biopharma is a clinical-stage biopharmaceutical company. Co.'s primary product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2 (AB201)) as a potential treatment for COVID-19, the disease syndrome caused by the SARS-CoV-2 virus, and potentially other viral diseases and Gencaro™ (bucindolol hydrochloride) for the treatment of atrial fibrillation in patients with chronic heart failure. rNAPc2 targets COVID-19 patients with biomarker evidence of coagulopathy, while Gencaro is being developed for patients who have a genotype that identifies a drug target associated with heightened efficacy. We show 28 historical shares outstanding datapoints in our coverage of ABIO's shares outstanding history.

Understanding the changing numbers of ABIO shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ABIO versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ABIO by allowing them to research ABIO shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree ABIO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
ARCA biopharma (ABIO) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

ABMD Shares Outstanding History
ABOS Shares Outstanding History
ABSI Shares Outstanding History
ABT Shares Outstanding History
ABVC Shares Outstanding History
ACAD Shares Outstanding History
ACCD Shares Outstanding History
ACER Shares Outstanding History
ACET Shares Outstanding History
ACHC Shares Outstanding History
More Healthcare companies »

 

ABIO Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.